Results 151 to 160 of about 1,296 (184)
Structural Basis for the Antibiotic Activity of Ketolides and Azalides [PDF]
The azalide azithromycin and the ketolide ABT-773, which were derived by chemical modifications of erythromycin, exhibit elevated activity against a number of penicillin- and macrolide-resistant pathogenic bacteria. Analysis of the crystal structures of the large ribosomal subunit from Deinococcus radiodurans complexed with azithromycin or ABT-773 ...
Frank Schlunzen +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Recent developments in macrolides and ketolides
Current Opinion in Microbiology, 1999Emergence of bacterial resistance to macrolide antibiotics, particularly in Gram-positive bacteria, has been observed. Novel macrolides having C-4" carbamate functional groups and ketolides, the 3-keto derivatives of macrolides, have been found to have activities against macrolide-resistant strains.
openaire +2 more sources
Effects of Macrolides and Ketolides on Mycobacterial Infections
Current Pharmaceutical Design, 2004New macrolides, such as clarithromycin and azithromycin, are active agents to Mycobacterium avium complex (MAC). Both clarithromycin and azithromycin are well-known for the ability to improve the prognosis of AIDS patients with disseminated MAC infection.
Luiz E, Bermudez, Yoshitaka, Yamazaki
openaire +2 more sources
Enfermedades infecciosas y microbiologia clinica, 2010
Macrolides and ketolides are two families of antibiotics that share the same mechanism of action. They bind to different bases of the peptidyl transferase center of 23S RNA. The antibacterial spectrum of these drugs virtually overlaps, but dissimilarities in the affinity and number of binding sites results in differences in the intensity of their ...
Nazaret, Cobos-Trigueros +3 more
openaire +1 more source
Macrolides and ketolides are two families of antibiotics that share the same mechanism of action. They bind to different bases of the peptidyl transferase center of 23S RNA. The antibacterial spectrum of these drugs virtually overlaps, but dissimilarities in the affinity and number of binding sites results in differences in the intensity of their ...
Nazaret, Cobos-Trigueros +3 more
openaire +1 more source
The Emerging New Generation of Antibiotic: Ketolides
Current Drug Targets - Infectious Disorders, 2001The bacterial ribosome is a target for a variety of drug classes including macrolides. Macrolide antibiotics are primarily used for the treatment of respiratory tract infections. One of the most important features of the macrolide class is the excellent safety profile allowing the drug to be used broadly across all age groups.
P, Zhong, V, Shortridge
openaire +2 more sources
Telithromycin: An Oral Ketolide for Respiratory Infections
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001The ketolides represent a new subclass of antibiotics among the macrolide‐lincosamide‐streptogramin group. Telithromycin, the first ketolide to be awarded approvable status for clinical use, demonstrates in vitro activity against community‐acquired respiratory pathogens including penicillin‐ and erythromycin‐resistant Streptococcus pneumoniae.
D T, Bearden, M M, Neuhauser, K W, Garey
openaire +2 more sources
Review of Macrolides and Ketolides
Drugs, 2001The first macrolide, erythromycin A, demonstrated broad-spectrum antimicrobial activity and was used primarily for respiratory and skin and soft tissue infections. Newer 14-, 15- and 16-membered ring macrolides such as clarithromycin and the azalide, azithromycin, have been developed to address the limitations of erythromycin.
G G, Zhanel +6 more
openaire +2 more sources
ABT-773: a new ketolide antibiotic
Expert Opinion on Investigational Drugs, 2001ABT-773 is a new semisynthetic derivative of erythromycin A, the ketolide class of broad spectrum antibacterial agents, in Phase II development by Abbott. With good broad spectrum activity against Gram-positive, some Gram-negative organisms and intracellular bacteria, ABT-773 is being developed as a respiratory agent. Structural changes in the ketolide
T J, Dougherty, J F, Barrett
openaire +2 more sources
Bioorganic & Medicinal Chemistry Letters, 2004
AbstractFor Abstract see ChemInform Abstract in Full Text.
Todd C, Henninger +8 more
openaire +2 more sources
AbstractFor Abstract see ChemInform Abstract in Full Text.
Todd C, Henninger +8 more
openaire +2 more sources
Structure-Activity Relationships for Six Ketolide Antibiotics
Current Microbiology, 2001Six structurally related 3-keto-substituted macrolide antibiotics (ketolides) were compared for concentration-dependent inhibitory effects on growth rate, viable cell number, and protein synthesis rates in Staphylococcus aureus cells. Inhibitory effects on 50S ribosomal subunit formation were also examined, as this is a second target for these ...
Champney, W. Scott, Tober, Craig L.
openaire +3 more sources

